in-vitro mouse melanoma model |
Growth inhibition |
Semi-synthetic form of α-tocopherol |
(+) |
ref. 49
|
in-vivo colon cancer mouse model |
Inhibited tumorigenesis |
Unspecified |
(+) |
ref. 51
|
Breast cancer for at risk women |
Remission of mammary dysplasia |
Synthetic α-tocopherol |
(+) |
ref. 50
|
Retrospective epidemiological study of breast cancer |
Negative association between breast cancer and vitamin E plasma |
Vit. E in serum (α-tocopherol) |
(+) |
ref. 11
|
Micronutrient intervention study of esophageal/gastric cancer |
Lower mortality in β-carotene, vitamin E and selenium group |
Unspecified |
(+) |
ref. 52
|
Randomized primary-prevention of lung cancer |
Significant reduction in prostate and increase in stomach cancer |
Synthetic α-tocopherol |
(+) prostate, (−) stomach |
ref 56 |
Meta-analysis of various cancers |
Only prostate cancer is lower |
|
(−) prostate |
ref. 57
|
Epidemiological study of breast cancer |
No association with breast cancer |
Unspecified |
no connection |
ref. 58
|
Epidemiological study of breast cancer |
No association with breast cancer |
Unspecified |
no connection |
ref. 59
|
Prospective cohort study of breast cancer |
No association with cancer incidence |
Unspecified |
no connection |
ref. 60
|
Breast and gynecological cancer study |
Higher vitamin E levels in cervical and endometrial cancers |
Unspecified α-tocopherol |
(−) |
ref. 61
|
Randomized control study of total and prostate cancer |
No effect of total or prostate cancer incidence |
Synthetic α-tocopherol |
no connection |
ref. 62
|
Prostate cancer prevention trial |
No effect on prostate cancer incidence |
Unspecified |
no connection |
ref. 63
|
Prostate cancer prevention trial |
Supplementation increased prostate cancer incidence |
Synthetic α-tocopherol |
(−) |
ref. 15
|